Inverness Graham Investments’ endodontic and restorative dental products manufacturing platform, Vista Apex Dental Products (Vista Apex), has acquired Palisades Dental, (Palisades), a manufacturer of specialised dental surgery handpieces. “We are pleased to support Vista Apex in its strategic acquisition of Palisades,” says Ryan Geary, Principal at Inverness Graham. “Palisades adds
Enhesa, a global compliance and sustainability business backed by CGE Partners (CGE), has completed the acquisition of Scivera. The deal marks the second add-on acquisition for Enhesa since CGE backed the company in July 2020 and is a further boost to CGE’s rapidly growing investment portfolio of high-growth European tech-enabled
European credit investment firm AlbaCore Capital Group (AlbaCore), is making a sustainability-linked investment of up to USD200 million in Babylon Holdings Limited (Babylon), one of the world’s fastest-growing digital healthcare companies. The interest rate on the notes is tied to the delivery of affordable healthcare to under-served populations. The
Nordstjernan’s wholly-owned subsidiary Etac has made an investment in 100 per cent of the shares in the US company Ki Mobility. The investment strengthens Etac’s global position in manual complex rehab and will create a strong platform for further growth in Europe, the US and export markets. Etac is
Funds advised by Apax are to acquire Eating Recovery Center (ERC Pathlight), a provider of eating disorder and mood and anxiety treatment in the US, in partnership with Oak HC/FT and management, from CCMP Capital. ERC Pathlight is a specialist in eating disorder treatment. The company’s differentiated clinical model meets
Arsenal Capital Partners (Arsenal), a private equity firm that specialises in investments in healthcare and industrial companies, has completed a majority recapitalisation of BioIVT, Inc (BioIVT) with Linden Capital Partners (Linden), a Chicago-based healthcare private equity firm. The terms of the transaction were not disclosed. Headquartered in Westbury, New York,
Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, has secured EUR5.4 million in financing via a flexible Convertible Notes Funding Programme (CNFP) from the Swiss investment firm Nice & Green. The flexible financing provided by this programme enables Marinomed
MIG Capital AG has sold portfolio company, Hemovent to MicroPort Surgical BV, a subsidiary of Shanghai-based MicroPort Scientific Corporation, (MicroPort) for a total purchase price of up to EUR123 million. Split between two funds MIG holds more than 27 per cent of Hemovent. Hemovent develops and manufactures Extra Corporal Lung
Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on next generation immune checkpoint targets, has closed a Series B round totalling EUR65 million. The financing was co-led by Athos Service GmbH – the Strüngmann family office – and MIG Capital AG, with participation from existing investors Wellington Partners,
Riata Capital Group (RCG) (Riata), a Dallas-based private equity investment firm, has closed a GP-led secondary transaction (the Transaction) for its portfolio company AEG Vision (AEG), an owner and operator of over 235 eyecare practices throughout North America. The Transaction allows RCG to return capital to certain existing investors while
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
